BURLINGTON PRIMARY CARE — All Prescriptions & Medications — Page 13
Practice Code: D83008 | IPSWICH, IP1 2EU
Showing results 601-650 of 659
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Phosphates (Rectal) | 12 | 459 | £753 | -1.8% vs avg |
| Propafenone hydrochloride | 12 | 720 | £107 | +10.8% ▲ |
| Bempedoic acid/Ezetimibe | 12 | 336 | £632 | -80.3% ▼ |
| Levocetirizine | 12 | 360 | £46 | -23.0% ▼ |
| Flupentixol hydrochloride | 12 | 364 | £50 | -45.3% ▼ |
| Lithium citrate | 12 | 6,000 | £444 | +33.5% ▲ |
| Perampanel | 12 | 336 | £1.6K | -44.6% ▼ |
| Opicapone | 12 | 356 | £700 | -37.3% ▼ |
| Vildagliptin | 12 | 336 | £93 | -17.3% ▼ |
| Dutasteride | 12 | 360 | £21 | -76.6% ▼ |
| Tamsulosin and dutasteride hydrochloride | 12 | 360 | £97 | -65.7% ▼ |
| Zinc sulfate monohydrate | 12 | 360 | £69 | +35.5% ▲ |
| Pyridoxine hydrochloride | 12 | 672 | £280 | -44.2% ▼ |
| Powder amino acid formula (0913107) | 12 | 44.0K | £2.8K | -63.7% ▼ |
| Atropine sulfate | 12 | 674 | £555 | -5.8% ▼ |
| Dexamethasone sodium metasulphobenzoate | 12 | 96 | £86 | +61.5% ▲ |
| Emulsifying wax | 12 | 6,000 | £44 | -1.5% vs avg |
| Zinc oxide | 12 | 4,430 | £117 | -40.3% ▼ |
| Ivermectin | 12 | 600 | £348 | -43.6% ▼ |
| Other toiletry preparations | 12 | 2,150 | £32 | -71.9% ▼ |
| 12 | 120 | £273 | -42.5% ▼ | |
| 12 | 360 | £526 | -41.1% ▼ | |
| 12 | 120 | £228 | -63.4% ▼ | |
| 12 | 600 | £63 | -43.3% ▼ | |
| 12 | 720 | £2.3K | -1.5% vs avg | |
| Selegiline hydrochloride | 11 | 616 | £98 | +0.3% vs avg |
| Fosfomycin trometamol | 11 | 11 | £51 | -61.3% ▼ |
| Soluble insulin (Neutral insulin) | 11 | 55 | £210 | +14.2% ▲ |
| Propylthiouracil | 11 | 1,176 | £115 | -12.5% ▼ |
| Indoramin | 11 | 330 | £264 | -27.6% ▼ |
| Powder 1 - 2.2 kcal/ml soup (0913011) | 11 | 828 | £712 | +43.2% ▲ |
| Ready to serve infant formula, high energy (0913104) | 11 | 127.9K | £1.6K | -0.4% vs avg |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 11 | 19.3K | £634 | -1.9% vs avg |
| Benzoyl peroxide | 11 | 390 | £67 | -21.9% ▼ |
| Heparinoid | 11 | 550 | £42 | -15.7% ▼ |
| Hepatitis A/hepatitis B | 11 | 11 | £330 | -35.0% ▼ |
| 11 | 55 | £58 | -62.0% ▼ | |
| 11 | 1,100 | £23 | -34.9% ▼ | |
| 11 | 11 | £89 | +10.0% ▲ | |
| 11 | 11 | £344 | +28.1% ▲ | |
| 11 | 350 | £19 | -79.7% ▼ | |
| 11 | 28 | £441 | +7.8% ▲ | |
| 11 | 30 | £762 | +20.8% ▲ | |
| 11 | 28 | £204 | -32.9% ▼ | |
| Diltiazem hydrochloride | 10 | 300 | £125 | +115.9% ▲ |
| Formoterol/glycopyrronium/budesonide | 10 | 10 | £423 | -83.4% ▼ |
| Flupentixol hydrochloride | 10 | 560 | £44 | -69.5% ▼ |
| Rimegepant | 10 | 68 | £877 | +1.9% vs avg |
| Pivmecillinam hydrochloride | 10 | 131 | £69 | -81.0% ▼ |
| Tube feed 1.5 kcal/ml higher protein (0914011) | 10 | 308.0K | £5.1K | +38.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.